Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Mar 25, 2020
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
Mar 24, 2020
Alector Reports 2019 Fourth Quarter and Full Year Financial Results and Business Highlights
Feb 05, 2020
Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
Feb 03, 2020
Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jan 31, 2020
Alector Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering
Jan 28, 2020
Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimer’s Disease Patients
Displaying 1 - 10 of 12